IGF2BP1 and urinary bladder carcinoma: IGF2BP1 could function as an m6A reader and enrich the 3'-UTR of immune checkpoint PD-L1 mRNA, thus enhancing the mRNA stability of PD-L1 in bladder cancer [32].